Hypertonic saline nasal provocation stimulates nociceptive nerves, substance P release, and glandular mucous exocytosis in normal humans

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 2, 1999, Pages 655-662

  Baraniuk, James N ^a,b,c   Ali, Mushtaq ^a,b,c   Yuta, Atsushi ^a,b,c   Fang, Sheen Yie ^a,b,c   Naranch, Kristina ^a,b,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b MIE UNIVERSITY   (Japan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; SUBSTANCE P;

ARTICLE; ASTHMA; BRONCHOSPASM; EXOCYTOSIS; HUMAN; HUMAN TISSUE; NOCICEPTION; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOMETRY;

EID: 0032793827     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.2.9805081     Document Type: Article

References (35)

1. 1. Anderson, S. D. 1996. Challenge tests to assess airway hyperresponsiveness and efficacy of drugs used in the treatment of asthma. J. Aerosol. Med. 9:95-109.
2. 2. Anderson, S. D., L. T. Rodwell, E. Daviskas, J. F. Spring, and J. du Toit. 1996. The protective effect of nedocromil sodium and other drugs on airway narrowing provoked by hyperosmolar stimuli: a role for the airway epithelium? J. Allergy Clin. Immunol. 98:S124-S134.
3. 3. Baraniuk, J. N. 1995. Neural receptors in normal and asthmatic lungs. Allergy Proc. 16:227-233.
4. 4. Braunstein, G., I. Fajac, J. Lacronique, and N. Frossard. 1991. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am. Rev. Respir. Dis. 144:630-636.
5. 5. Okamoto, Y., K. Shirotori, K. Kudo, K. Ishikawa, E. Ito, K. Togaw, and I. Saito. 1993. Cytokine expression after the topical administration of substance P to human nasal mucosa: the role of substance P in nasal allergy. J. Immunol. 151:4391-4398.
6. 6. McDonald, D. M. 1988. Neurogenic inflammation in the rat trachea: I. Changes in venules, leukocytes and epithelial cells. J. Neurocytol. 17: 605-628.
7. 7. Piedemonte, G., D. M. McDonald, and J. A. Nadel. 1990. Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea. J. Clin. Invest. 86:1409-1415.
8. 8. Baraniuk, J. N., J. D. Lundpren, M. Okayama, J. Goff, J. Mullol, M. Merida, J. H. Shelhamer, and M. A. Kaliner. 1991. Substance P and neurokinin A (NKA) in human nasal mucosa. Am. J. Respir. Cell Mol. Biol 4:228-236.
9. 9. Sanico, A. M., S. Atsuta, D. Proud, and A. Togias. 1997. Dose dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J. Allergy Clin. Immunol. 100:632-641.
10. 10. Mosimman, B. L., M. V. White, R. J. Hohman, M. S. Goldrich, H. C. Kaulbach, and M. A. Kaliner. 1993. Substance P, calcitonin-gene related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J. Allergy Clin. Immunol. 92:95-104.
11. 11. Svensson, C., M. Andersson, L. Greiff, U. Alkner, and C. G. A. Persson. 1995. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin. Exp. Allergy 25:942-950.
12. 12. Joos, G. F., P. R. Germonpre, and R. A. Pauwels. 1995. Neurogenic inflammation in human airways: is it important? Thorax 50:217-219.
13. 13. Raphael, G. R., J. N. Baraniuk, and M. A. Kaliner. 1991. How and why the nose runs. J. Allergy Clin. Immunol. 87:457-467.
14. 14. Lai, G., G. Philip, and A. Togias. 1996. The nasal response to hyperosmolar saline is inhibited by capsaicin treatment (abstract). J. Allergy Clin. Immunol. 97:A431.
15. 15. Rinder, J., P. Stjarne, and M. Lundberg. 1994. Capsaicin de-sensitization of the human nasal mucosa reduces pain and vascular effects of lactic acid and hypertonic saline. Rhinology 32:173-178.
16. 16. Caterina, M. J., M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, and D. Julius. 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816-824.
17. 17. Ali, M., J. Maniscalco, and J. N. Baraniuk. 1996. Spontaneous release of submucosal gland serous and mucous cell macromolecules from human nasal explants in vitro. Am. J. Physiol. 270:L595-L600.
18. 18. Baraniuk, J. N., P. B. Silver, M. A. Kaliner, and P. J. Barnes. 1994. Perennial rhinitis subjects have altered vascular, glandular, and neural responses to bradykinin nasal provocation. Int. Arch. Allergy Immunol. 103:202-208.
19. 19. Baraniuk, J. N., M. Ali, D. Brody, J. Maniscalco, E. Gaumond, T. Fitzgerald, G. Wong, A. Yuta, J. Mak, P. J. Barnes, R. Bascom, and T. Troost. 1997. Glucocorticoids induce 82 adrenergic receptors in human nasal mucosa. Am. J. Respir. Crit. Care Med. 155:704-710.
20. 20. Kesavanthan, J., D. L. Swift, and R. Bascom. 1995. Nasal pressure-volume relationships determined with acoustic rhinometry. J. Appl. Physiol. 79:547-553.
21. 21. Nuovo, G. J., F. Gallery. P. MacConnell, J. Becker, and W. Block. 1991. An improved technique for the in situ detection of DNA after polymerase chain reaction amplification. Am. J. Pathol. 139:1239-1244.
22. 22. Takahashi, K., A. Tanaka, M. Hara, and S. Nakanishi. 1992. The primary structure and gene organization of human substance P and neuromedin K receptors. Eur. J. Biochem. 204:1025-1033.
23. 23 Gerard, N. P., R. L. Eddy, T. B. Shows, and C. Gerard. 1990. The human neurokinin A (substance K) receptor: molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues. J. Biol. Chem. 265:20455-20462.
24. 24. Tsuchida, K., R. Shigemoto, Y. Yokota, and S. Nakanishi. 1990. Tissue distribution and quantification of the mRNAs for three rat tachykinin receptors. Eur. J. Biochem. 193:751-757.
25. 25. Meinkoth, J., and G. Wahl. 1984. Hybridization of nucleic acids immobilized on solid supports. Anal. Biochem. 138:267-284.
26. 26. Tos, M. 1982. Distribution of mucus producing elements in the respiratory tract: differences between upper and lower airways. Eur. J. Respir. Dis. Suppl. 128:269-279.
27. 27. Carstairs, J. R., and P. J. Barnes. 1988. Autoradiographic mapping of substance P receptors in lung. Eur. J. Pharmacol. 127:295.
28. 28. Togias, A., K. Lykens, A. Kagey-Sobotka, P. A. Eggleston, D. Proud, L. M. Lichtenstein, and R. M. Naclerio. 1990. Studies on the relationships between sensitivity to cold, dry air, hyperosmolar solutions and histamine in the adult nose. Am. Rev. Respir. Dis. 141:1428-1433.
29. 29. Ricchio, M. M., C. J. Reynolds, D. W. Hay, and D. Proud. 1995. Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am. J. Respir. Crit. Care Med. 152:1757-1764.
30. 30. Stjarne, P., J. S. Lacroix, A. Anggard, and J. M. Lundberg. 1991. Compartment analysis of vascular effects of neuropeptides and capsaicin in the pig nasal mucosa. Acta Physiol. Scand. 141:335-342.
31. 31. Stjarne, P., L. Lundblad, J. M. Lundberg, and A. Anggard. 1989. Capsaicin and nicotine sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br. J. Pharmacol. 96:693-701.
32. 32. Bai, T. R., D. Zhou, T. Weir, B. Walker, R. Hegele, S. Ayashi, K. McKay, G. P. Bondy, and T. Fong. 1995. Substance P (NK1)-and neurokinin A (NK2)-receptor expression in inflammatory airway disease. Am. J. Physiol. 269:L309-L317.
33. 33. Claman, D. M., H. A. Boushey, J. Liu, H. Wong, and J. V. Fahy. 1994. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J. Allergy Clin. Immunol. 94:861-869.
34. 34. Bacci, E., S. Cianchetti, P. L. Paggiaro, S. Carnevali, L. Barncalari, F. L. Dente, A. Difranco, D. Giannini, B. Vagaggini, and C. Giuntini. 1996. Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma. Clin. Exp. Allergy 26:1395-1400.
35. 35. Tomaki, M., M. Ichinose, M. Miura, Y. Hirayama, H. Yamauchi, N. Nakajima, and K. Shirato. 1995. Elevated substance P content induced sputum from patients with asthma and patients with chronic bronchitis. Am. J. Respir. Crit. Care Med. 151:613-617.